Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool
Open Access
- 1 April 2004
- journal article
- review article
- Published by Elsevier BV in Molecular & Cellular Proteomics
- Vol. 3 (4), 367-378
- https://doi.org/10.1074/mcp.r400007-mcp200
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Diagnostic Potential of Serum Proteomic Patterns in Prostate CancerJournal of Urology, 2003
- The Vision for a New Diagnostic ParadigmClinical Chemistry, 2003
- Recruiting Genes, Proteins for a Revolution in DiagnosticsScience, 2003
- The case for early detectionNature Reviews Cancer, 2003
- Mass spectrometry-based proteomicsNature, 2003
- Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixturesProstate Cancer and Prostatic Diseases, 1999
- NMR — Another Cancer-Test DisappointmentNew England Journal of Medicine, 1990
- Proton Nuclear Magnetic Resonance Spectroscopy of Plasma from Healthy Subjects and Patients with CancerNew England Journal of Medicine, 1990
- Detection of Malignant TumorsNew England Journal of Medicine, 1986
- Serum haptoglobin and α1-acid glycoprotein as indicators of the effectiveness of cis-diamminedichloroplatinum (CDDP) in ovarian cancer patients—a preliminary reportEuropean Journal of Cancer and Clinical Oncology, 1984